Pivotal bioVenture Partners Investment Advisor LLC

Venture Capital

CIK

1844645

Location

SAN FRANCISCO, CA

Portfolio Value

Small $307,788,408

Diversification

Diversified

Reports for

Pivotal bioVenture Partners Fund I U.G.P. Ltd

Filing Date

Global Rank

#5,163 / 8,794 ▼ 503 · as of Jun 2026

Top Industry

Biotechnology 94.8%

Period ended 3 months ago

Filed Aug 13, 2026 · 52d

23 quarters · since Dec 2020

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

13 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

26.9%

−1.6 pts

Top 5

66.9%

−11.4 pts

Top 10

95.1%

−3.2 pts

HHI

1,304

Diversified−279

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$307,788,408	13

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

3 positions

Ticker	Company	Δ Shares	Shares	Value
TRVI	Trevi Therapeutics, Inc.	+188,946	1,742,672	$32,500,832
AVTX	Avalo Therapeutics, Inc.	+138,100	434,033	$8,020,929
PCVX	Vaxcyte, Inc.	+53,045	1,425,470	$82,862,571
No positions match the current search.

Trimmed

Positions the filer reduced

4 positions

Ticker	Company	Δ Shares	Shares	Value
OCS	Oculis Holding AG	−174,033	1,506,250	$20,891,687
ZBIO	Zenas BioPharma, Inc.	−101,225	490,766	$12,455,641
ARQT	Arcutis Biotherapeutics, Inc.	−90,609	1,265,283	$33,175,720
MPLT	MapLight Therapeutics, Inc.	−1	611,446	$21,914,224
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
AVLN	Avalyn Pharma Inc.	966,792	$31,826,792
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
BOLT	Bolt Biotherapeutics, Inc.	42,581	$172,027
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

13 tracked positions · $307,788,408 total · filing declares 13 positions · $307,788,414 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
PCVX	Vaxcyte, Inc. Healthcare	Added	1,425,470	+53,045	$82,862,571	+3.9%	26.92%
ARQT	Arcutis Biotherapeutics, Inc. Healthcare	Reduced	1,265,283	-90,609	$33,175,720	+3.9%	10.78%
TRVI	Trevi Therapeutics, Inc. Healthcare	Added	1,742,672	+188,946	$32,500,832	+75.3%	10.56%
AVLN	Avalyn Pharma Inc. Healthcare	NEW	966,792	NEW	$31,826,792	NEW	10.34%
EVMN	Evommune, Inc. Healthcare	Held	1,926,943	0	$25,609,072	−42.2%	8.32%
MPLT	MapLight Therapeutics, Inc. Healthcare	Reduced	611,446	-1	$21,914,224	+76.3%	7.12%
OCS	Oculis Holding AG Healthcare	Reduced	1,506,250	-174,033	$20,891,687	−53.2%	6.79%
BIOA	BioAge Labs, Inc. Healthcare	Held	653,374	0	$16,014,196	+40.1%	5.20%
IMNM	Immunome Inc. Healthcare	Held	732,512	0	$15,521,929	−3.1%	5.04%
ZBIO	Zenas BioPharma, Inc. Healthcare	Reduced	490,766	-101,225	$12,455,641	+7.6%	4.05%
AVTX	Avalo Therapeutics, Inc. Healthcare	Added	434,033	+138,100	$8,020,929	+81.5%	2.61%
RLYB	Rallybio Corp Healthcare	Held	300,579	0	$4,809,264	+78.4%	1.56%
RXRX	Recursion Pharmaceuticals, Inc. Healthcare	Held	595,518	0	$2,185,551	+19.5%	0.71%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.